In competitive enzyme and protein markets, companies require:
Developing high-performance enzymes while building independent intellectual property is a key strategic priority.
Neoncorte Bio designs novel enzyme variants using AI-driven protein engineering, enabling clients to build proprietary biocatalyst portfolios aligned with their commercial goals.
This approach enables creation of new, proprietary enzyme solutions, rather than incremental modification of known variants.